The ten-year survival rate for medulloblastoma wnt type is around 87%.
The wnt type of medulloblastoma, the subtype of medulloblastoma that presents with overexpression of the wnt pathway, accounts for about 11% of all medulloblastoma cases.
The wnt type is predominantly seen in children but can also occur in adults and is rare in infants. Of all the subgroups, the wnt subgroup has the most favorable prognosis, with a ten-year survival rate of about 87% and a five-year survival rate of >95%. wnt type has a better prognosis may have an effective role for chemotherapeutic agents within the tumor lesion.
Medulloblastoma wnt type current treatment preferred surgical resection, postoperative supplemented with radiation, chemotherapy. Existing treatment regimens have resulted in overall patient survival rates of up to 70%. However, excessive radiotherapy and chemotherapy can cause damage to children’s auditory, cognitive, endocrine, and vascular systems, and long-term tumor survival remains poor.
Patients should seek treatment for medulloblastoma in a timely manner to avoid delays.